Medicenna Presents Phase 1/2 ABILITY Study Data

-- New data show that MDNA11 boosted the lymphocyte population by 2-fold without inducing significant increases in eosinophils (associated with toxicity) ...

Related Keywords

Canada ,Houston ,Texas ,United States ,Toronto ,Ontario ,Superkine Immunotherapies ,Geok Choo ,Medicenna Therapeutics Corp ,York Academy Of Sciences ,Annual Frontiers ,New York Academy ,Fahar Merchant ,Exhibiting Potent Tumor Growth Control ,Preclinical Models ,Preferential Expansion ,Advanced Solid Tumors ,England Journal ,Orphan Drug ,Nasdaq Mdna ,